Henry's Feed
Mar 18, 2012

Insight: Cheap generics no panacea for India’s poorest

MUMBAI (Reuters) – Cheap generic drugs were meant to change the life of Nandakhu Nissar, whose mouth is swollen by a cancerous tumor. But the cashless and hungry 55-year-old sleeps on a pavement staring up at the windows of Mumbai’s biggest cancer hospital.

“What is a generic drug?” shrugs Nissar, who has travelled over 1,500 km (900 miles) from his home in the hope of treatment.

Mar 16, 2012

India car makers boosted by budget; excise hike irks

MUMBAI, March 16 (Reuters) – Indian automakers heaved
a sigh of relief after the federal budget did not hike taxes on
diesel cars and retained a generous subsidy on the fuel, but
companies criticized a rise in excise duty that will trigger an
increase in car prices.

Any measures in the budget to specifically make diesel cars
more expensive to buy or run might have poured cold water on a
segment that has boosted sales even as overall demand slows on
high interest rates and rising petrol prices.

Mar 16, 2012

Car makers race ahead on friendly Budget

MUMBAI (Reuters) – Indian car makers heaved a sigh of relief and saw their shares soar after the federal budget did not hike taxes on diesel cars, in a boost for diesel-focused manufacturers such as Mahindra and Mahindra and Tata Motors.

Carmakers in India had feared a tax on diesel vehicles or a reduction in the fuel’s generous subsidy , which has boosted sales as overall demand slows on high interest rates and rising petrol prices in Asia’s third-largest economy.

Mar 16, 2012

India car makers race ahead on friendly budget

MUMBAI, March 15 (Reuters) – Indian car makers heaved
a sigh of relief and saw their shares soar after the federal
budget did not hike taxes on diesel cars, in a boost for
diesel-focused manufacturers such as Mahindra and Mahindra
and Tata Motors.

Carmakers in India had feared a tax on diesel vehicles or a
reduction in the fuel’s generous subsidy , which has
boosted sales as overall demand slows on high interest rates and
rising petrol prices in Asia’s third-largest economy.

Mar 14, 2012

Kingfisher cuts back on overseas flights

MUMBAI/HYDERABAD, India (Reuters) – India’s Kingfisher Airlines (KING.NS: Quote, Profile, Research, Stock Buzz) will scale back overseas flights to cut costs and attract funding from sceptical investors, but the country’s aviation regulator accused it on Wednesday of reneging on a recovery plan and British Airways said it had suspended a code-sharing pact with airline.

Cash-strapped and debt-laden, Kingfisher has slashed its operating schedule and is scrambling for financing from creditors as its losses grow in India’s fiercely-competitive airline industry.

Mar 14, 2012

Kingfisher Air to cut back overseas flights

MUMBAI (Reuters) – Kingfisher Airlines will cut back its overseas flights as the debt-crippled and cash-strapped carrier looks to slash costs and attract funding from wary bankers and sceptical investors.

Cutting its costly and loss-making international flights is seen as a necessary step by industry analysts if Kingfisher is to salvage its flagging business. It might not however, be enough to bring bankers back to the table.

Mar 14, 2012

India’s Kingfisher Air to cut back overseas flights

MUMBAI, March 14 (Reuters) – India’s troubled
Kingfisher Airlines will cut back its overseas flights
as the debt-crippled and cash-strapped carrier looks to slash
costs and attract funding from wary bankers and sceptical
investors.

Cutting its costly and loss-making international flights is
seen as a necessary step by industry analysts if Kingfisher is
to salvage its flagging business. It might not however, be
enough to bring bankers back to the table.

Mar 13, 2012

India cancer ruling opens door for cheaper drugs

MUMBAI (Reuters) – India’s move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.

On Monday, the Indian Patent Office effectively ended Bayer’s (BAYGn.DE: Quote, Profile, Research) monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma (NATP.NS: Quote, Profile, Research) to make and sell the drug cheaply in India.

Mar 13, 2012

Analysis: India patent ruling may open door for cheaper HIV drugs

MUMBAI (Reuters) – India’s move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.

On Monday, the Indian Patent Office effectively ended Bayer’s monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug cheaply in India.

Mar 13, 2012

India patent ruling may open door for cheaper HIV drugs

MUMBAI (Reuters) – India’s move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.

On Monday, the Indian Patent Office effectively ended Bayer’s monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug cheaply in India.